Minahasa Membangun Hebat Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Minahasa Membangun Hebat Tbk. trades at Rp218 (market cap 231.04B, 141.6K 24h volume), while Prodia Diagnostic Line Tbk trades at Rp266 (market cap 470.58B, 16.61M 24h volume). The key difference: Prodia Diagnostic Line Tbk is far larger — about 2× Minahasa Membangun Hebat Tbk.'s market cap, and Prodia Diagnostic Line Tbk is more actively traded (16.61M versus 141.6K). Which is the better fit depends on your goals.
| HBAT | PRDL | |
|---|---|---|
Market Cap | 231.04B | 470.58B |
Volume | 141.6K | 16.61M |
Lot | 1.42K | 166.06K |
Turnover | 30.8M | 4.38B |
Average Price | 217.53 | 263.54 |
Value | 30.8M | 4.38B |
Indicative Equilibrium Price | — | 272 |
Indicative Equilibrium Volume | — | 418 |
Trailing returns across standard periods
Latest headlines on both assets
PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.
Read more on HBAT →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →